Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Demoralization in Parkinson disease
Brian B Koo1, Christopher A Chow2, Divya R Shah2
1From the Department of Neurology (B.B.K., C.A.C., D.R.S., F.H.K., B.S., D.D., K.N., K.S.P., V.M.K., A.S.P., E.D.L.), Center for Neuroepidemiology and Clinical Neurologic Research (B.B.K., E.D.L.), Department of Psychiatry (J.M.d.F.), Yale University; and Department of Chronic Disease Epidemiology (E.D.L.), Yale School of Public Health, Yale University, New Haven, CT. brian.koo@yale.edu.
Demoralization affects nearly one-fifth of Parkinson
Area of Science:
- Neurology
- Psychiatry
- Clinical Psychology
Background:
- Demoralization is a distinct clinical entity characterized by an inability to cope.
- It is crucial to differentiate demoralization from depression, as treatment strategies differ.
- Understanding demoralization's prevalence in Parkinson's disease (PD) is essential for targeted interventions.
Purpose of the Study:
- To investigate the prevalence of demoralization in individuals with Parkinson's disease (PD).
- To identify features associated with demoralization in the PD population.
- To compare demoralization rates between PD patients and healthy controls.
Main Methods:
- Prospective recruitment of PD patients and controls from movement disorder clinics and the community.
- Demoralization assessed using the Diagnostic Criteria for Psychosomatic Research Demoralization questionnaire or Kissane Demoralization Scale (≥24).
- Depression assessed using the Patient Health Questionnaire-9 (≥10); logistic regression analyzed associations.
Main Results:
- Demoralization was present in 18.1% of PD patients versus 8.1% of controls (p=0.05).
- PD patients showed a higher likelihood of demoralization (OR 2.60, p=0.051), associated with younger age and single status.
- In PD patients, demoralization correlated with younger age and motor impairment (UPDRS Part III score).
Conclusions:
- Demoralization is a common condition in Parkinson's disease, often linked to motor dysfunction.
- Demoralization is distinct from depression, marked by an impaired ability to cope.
- Identifying demoralization in PD patients is critical for implementing appropriate and distinct treatment plans.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Alzheimer's Disease: Treatment
Principles of Disease Surveillance

